Skip to main content
Carla Casulo, MD, Hematology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

CarlaCasuloMD

Hematology • Rochester, NY

Hematologic Oncology

Associate Professor, Medicine, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Casulo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Casulo's full profile

Already have an account?

  • Office

    Wilmot Cancer Institute 601 Elmwood Ave
    Rochester, NY 14642
    Phone+1 585-275-5823
    Fax+1 585-273-1051
  • Is this information wrong?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2012
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2004 - 2008
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2004

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2008 - 2025
  • CT State Medical License
    CT State Medical License 2007 - 2008
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Venetoclax plus R- or G-CHOP in Non-Hodgkin Lymphoma: Results from the CAVALLI Phase 1b Trial  
    Andrew D Zelenetz, Andre Goy, Mehrdad Mobasher, Carla Casulo, Blood

Abstracts/Posters

  • Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
    Carla Casulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
    Carla Casulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
    Carla Casulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The effect of duvelisib, a dual inhibitor of PI3K-I on components of the tumor microenvironment in previously untreated follicular lymphoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • POD24 Predicts Poor Prognosis in Follicular Lymphoma
    POD24 Predicts Poor Prognosis in Follicular LymphomaDecember 1st, 2021
  • Wilmot Hosts Deaf High School Students for Internship, Inspiring New Career Possibilities
    Wilmot Hosts Deaf High School Students for Internship, Inspiring New Career PossibilitiesAugust 13th, 2021
  • Finding Family and France, Figuratively: One Lymphoma Patient's Stem Cell Transplant Story
    Finding Family and France, Figuratively: One Lymphoma Patient's Stem Cell Transplant StoryJune 3rd, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations

Dr. Carla Casulo, Dr. Carla Casulo, MD, Dr. C Casulo